The Impact of Tonsillectomy Techniques on Secondary Tonsillectomy Bleeding (NCT07763704) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
The Impact of Tonsillectomy Techniques on Secondary Tonsillectomy Bleeding
100 participantsStarted 2026-09
Plain-language summary
Post-tonsillectomy hemorrhage (PTH) is one of the most common and potentially life-threatening complications of tonsillectomy.
* Secondary PTH (Bleeding occurring \>24 hours post-operatively) is of particular clinical significance.
* Tonsillectomy is a frequently performed procedure at Assiut University Hospital (AUH).
* However, no local prospective data exists comparing secondary PTH rates across techniques, or systematically characterizing its causes.
* This study addresses this gap by comparing rates, and analysis of causes.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Secondary PTH (bleeding \>24 hours post-tonsillectomy)
* Tonsillectomy surgical technique: cold steel, bipolar diathermy, or Coblation
* Any patient age (pediatric and adult patient are included)
* Presenting to the AUH Emergency Department or ENT clinic
Informed consent obtained (written parental consent + written child assent for patients under 18 years)
Exclusion Criteria:
* Primary PTH (bleeding ≤24 hours post-op)
* Tonsillectomy technique other than the three study techniques (e.g., laser, harmonic scalpel)
* External approach tonsillectomy
* Known bleeding disorder (pre-existing coagulopathy)
* Concurrent head and neck malignancy
* Refusal of informed consent
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.